Trending...
- Southern Soul Artist Moe Z Releases New Single 'Set It Out' Distributed by Morris Day Entertainment
- Skool Alternatives Reddit: Skool vs Circle vs Whop - Did you join one yet?
- Cal State LA secures funding for two artificial intelligence projects from CSU
IRVINE, Calif. and LONDON, July 22, 2024 ~ London, UK - Medical and Commercial International Limited (MCI), a leading specialized liability underwriting company, has joined forces with GATC Health Corp, a technology company utilizing artificial intelligence in drug discovery, to launch a groundbreaking program that will revolutionize the financing of clinical trials. This first-of-its-kind initiative, approved by Lloyd's of London, will provide insurance coverage for biotech companies in the event of trial failure.
The partnership between MCI and GATC Health aims to mitigate the financial risks associated with medical innovation and research. By utilizing GATC Health's proprietary AI technology, which accurately forecasts clinical trial endpoints, this new insurance model will significantly enhance risk assessment and promote the growth of therapeutic drug development.
MCI CEO Phil Trafford expressed excitement about this new venture, stating that "clinical trial funding insurance is a revolutionary product with high demand in the market." He believes that working alongside lenders and investors, this program will not only support medical innovation but also provide unparalleled risk assessment accuracy.
More on The Californer
The biotech industry has long struggled with securing funding for drug development projects without compromising equity or control of their company. This new program addresses these challenges by utilizing GATC Health's technology to enhance the risk selection process and bring more therapeutic drugs to market.
Ben Canagaretna, Global Managing Director of Acrisure Re Corporate Advisory & Solutions (ARCAS), an international financing and consulting firm responsible for program sales and distribution, praised GATC Health's AI technology for enabling this unique combination of financing and insurance. He also noted that the response from biotech companies and large brokerage firms has exceeded expectations, highlighting the pent-up demand for innovative financing programs.
GATC Health CEO John Stroh emphasized their focus on using AI technology to develop safer and more effective drugs in less time and with less money. Through their partnership with MCI backed by Lloyd's of London, they aim to transform the financial model of drug development and bring better treatments to those in need.
More on The Californer
This collaboration between MCI and GATC Health, with the backing of Lloyd's, marks a significant development in the insurance industry. It promises to reshape the landscape of clinical trial funding and provide stakeholders in the biotech industry with enhanced risk management tools to unlock groundbreaking medical innovations.
GATC Health's Multiomics Advanced Technology™ (MAT) platform, which utilizes AI and machine learning to simulate human physiology, has already shown promising results. In just two years, it has discovered and tested seven drug candidates with the potential to create 10 to 12 novel molecules each year. With this technology, the likelihood of clinical trial success is significantly increased.
The launch of this program marks a new era in clinical trial financing, where innovative technology and insurance come together to support medical innovation and bring life-changing treatments to those who need them most. With Lloyd's endorsement, this partnership between MCI and GATC Health is set to transform the drug development landscape for years to come.
The partnership between MCI and GATC Health aims to mitigate the financial risks associated with medical innovation and research. By utilizing GATC Health's proprietary AI technology, which accurately forecasts clinical trial endpoints, this new insurance model will significantly enhance risk assessment and promote the growth of therapeutic drug development.
MCI CEO Phil Trafford expressed excitement about this new venture, stating that "clinical trial funding insurance is a revolutionary product with high demand in the market." He believes that working alongside lenders and investors, this program will not only support medical innovation but also provide unparalleled risk assessment accuracy.
More on The Californer
- Buy The Crave Launches Premium Creatine and Natural Wellness Supplements for Modern Lifestyles
- Long Beach Parks, Recreation and Marine's Homeland Cultural Center Presents DanceFest at Cesar Chavez Park Amphitheater on August 16
- Sisu, a Portrait of Grit, Connection and Triumph, Premieres on Documentary Showcase
- New Liz Taylor Book Coming Soon: Chasing Elizabeth Taylor
- City of Long Beach Experienced a 4% Decrease in Fireworks-Related Reports on July 4
The biotech industry has long struggled with securing funding for drug development projects without compromising equity or control of their company. This new program addresses these challenges by utilizing GATC Health's technology to enhance the risk selection process and bring more therapeutic drugs to market.
Ben Canagaretna, Global Managing Director of Acrisure Re Corporate Advisory & Solutions (ARCAS), an international financing and consulting firm responsible for program sales and distribution, praised GATC Health's AI technology for enabling this unique combination of financing and insurance. He also noted that the response from biotech companies and large brokerage firms has exceeded expectations, highlighting the pent-up demand for innovative financing programs.
GATC Health CEO John Stroh emphasized their focus on using AI technology to develop safer and more effective drugs in less time and with less money. Through their partnership with MCI backed by Lloyd's of London, they aim to transform the financial model of drug development and bring better treatments to those in need.
More on The Californer
- The Blue Luna Encourages Local Schools to Take Steps to Enhance Safety for Students and Staff
- Wise Business Plans Launches Turnkey Startup Packages to Help Entrepreneurs Start and Scale
- CarSeek Re-Launch: A New Look, A Better Experience for Car Buyers
- California: Governor Newsom provides $11 million to organizations helping underserved job seekers find training and employment
- For Artificial Intelligence Appreciation Day: Celebrate it with a poem about AI called "Robot Love"
This collaboration between MCI and GATC Health, with the backing of Lloyd's, marks a significant development in the insurance industry. It promises to reshape the landscape of clinical trial funding and provide stakeholders in the biotech industry with enhanced risk management tools to unlock groundbreaking medical innovations.
GATC Health's Multiomics Advanced Technology™ (MAT) platform, which utilizes AI and machine learning to simulate human physiology, has already shown promising results. In just two years, it has discovered and tested seven drug candidates with the potential to create 10 to 12 novel molecules each year. With this technology, the likelihood of clinical trial success is significantly increased.
The launch of this program marks a new era in clinical trial financing, where innovative technology and insurance come together to support medical innovation and bring life-changing treatments to those who need them most. With Lloyd's endorsement, this partnership between MCI and GATC Health is set to transform the drug development landscape for years to come.
Filed Under: Business
0 Comments
Latest on The Californer
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- Cal State LA secures funding for two artificial intelligence projects from CSU
- Colbert Packaging Announces WBENC Recognition
- New Mobile Car Detailing Platform Connects Drivers with On-Demand Local Pros
- Over the past three months, California seized $476 million worth of unlicensed cannabis products
- California scores more clean energy records: 9 in 10 days this year partially powered by 100% clean energy
- "Mobile Suit Gundam" Takes Over San Diego Comic-Con 2025
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Hamilton Zanze Sponsors the Acquisition of Two Garden-Style Communities in Reno Area
- Meet a Scientologist Captures Greece's Timeless Beauty with Videographer Lambros Malamas
- Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
- Moovs Launches Advanced Contact Center Solution for Large-Scale Transportation Operations
- Centennial Flyers to Become Colorado's First Launch Customer for All-Electric B23 Energic Aircraft
- Second Annual Artists' Rights Advocate Award to Be Presented at The Comedy Store on July 17th
- Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- Ship Overseas Inc. Expands Specialized Shipping Services
- Governor Newsom announces additional deployment of California resources to support New Mexico following Texas and Oregon disaster response efforts